| abstract |
The invention relates to a pharmaceutical product comprising antiandrogen and tamoxifen, wherein the antiandrogen is selected from flutamide, nilutamide, chlormadinone acetate and cyproterone or a pharmaceutically acceptable salt or solvate thereof, daily dose or dose Regarding the plan. The present invention further relates to a method of providing an anti-androgenic and anti-estrogenic effect to a patient, wherein the method does not substantially cause an additional increase in circulating androgen levels. |